Skip to main content

sec filings

Insider trades

Open-market buys and sales that company insiders report to the SEC on .

Side
Planned sales
Role
LTGO

Updated 10/6/2026, 6:18 PM ET.

LTGO

Latigo Biotherapeutics, Inc.

Buy$2,520,000

Foresite Capital Management V, LLC

10% owner

and 5 others

140,000 shat $18.00Filed Aug 10, 8:21 PM ETFiling
LTGO

Latigo Biotherapeutics, Inc.

Buy$2,520,000

Tananbaum James B.

Director, 10% owner

140,000 shat $18.00Filed Aug 10, 8:00 PM ETFiling

Read from public SEC filings. Not financial advice.